Nan Fung Group Holdings as of June 30, 2023
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 43 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 31.3 | $49M | 226k | 216.85 | |
| Illumina (ILMN) | 14.3 | $22M | 119k | 187.49 | |
| Harmony Biosciences Hldgs In (HRMY) | 8.3 | $13M | 369k | 35.19 | |
| Seagen | 5.8 | $9.1M | 47k | 192.46 | |
| Oculis Holding Ordinary Shares (OCS) | 5.1 | $8.0M | 651k | 12.33 | |
| Exscientia Ads (EXAI) | 3.3 | $5.1M | 860k | 5.92 | |
| Iveric Bio | 2.8 | $4.4M | 112k | 39.34 | |
| Xenon Pharmaceuticals (XENE) | 2.8 | $4.4M | 114k | 38.50 | |
| Chinook Therapeutics | 2.8 | $4.4M | 114k | 38.42 | |
| Replimune Group (REPL) | 2.7 | $4.3M | 185k | 23.22 | |
| Merus N V (MRUS) | 2.5 | $4.0M | 151k | 26.33 | |
| Somalogic Class A Com | 2.5 | $3.9M | 1.7M | 2.31 | |
| Beigene Sponsored Adr (BGNE) | 1.4 | $2.1M | 12k | 178.30 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 1.3 | $2.0M | 494k | 4.12 | |
| Incyte Corporation (INCY) | 1.3 | $2.0M | 32k | 62.25 | |
| Galera Therapeutics (GRTX) | 1.2 | $1.9M | 613k | 3.12 | |
| Kalvista Pharmaceuticals (KALV) | 1.2 | $1.8M | 205k | 9.00 | |
| Pacific Biosciences of California (PACB) | 1.2 | $1.8M | 137k | 13.30 | |
| Bolt Biotherapeutics (BOLT) | 1.0 | $1.5M | 1.2M | 1.28 | |
| Geron Corporation (GERN) | 0.8 | $1.2M | 388k | 3.21 | |
| Exelixis (EXEL) | 0.8 | $1.2M | 64k | 19.11 | |
| Biomea Fusion (BMEA) | 0.6 | $878k | 40k | 21.95 | |
| Aerovate Therapeutics (AVTE) | 0.5 | $822k | 48k | 17.15 | |
| Entrada Therapeutics (TRDA) | 0.5 | $743k | 49k | 15.14 | |
| Eargo Com New | 0.5 | $729k | 148k | 4.93 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $718k | 30k | 23.95 | |
| Dbv Technologies S A Sponsored Adr | 0.5 | $705k | 371k | 1.90 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $661k | 40k | 16.49 | |
| Argenx Se Sponsored Adr (ARGX) | 0.4 | $557k | 1.4k | 389.73 | |
| Cabaletta Bio (CABA) | 0.3 | $531k | 41k | 12.91 | |
| Gitlab Class A Com (GTLB) | 0.2 | $353k | 6.9k | 51.11 | |
| Reata Pharmaceuticals Cl A | 0.2 | $337k | 3.3k | 101.96 | |
| Alx Oncology Hldgs (ALXO) | 0.2 | $315k | 42k | 7.51 | |
| BioMarin Pharmaceutical (BMRN) | 0.2 | $313k | 3.6k | 86.68 | |
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $273k | 1.2k | 231.00 | |
| Affimed Therapeutics B V | 0.1 | $223k | 373k | 0.60 | |
| Akero Therapeutics (AKRO) | 0.1 | $207k | 4.4k | 46.69 | |
| Fibrogen (FGEN) | 0.1 | $168k | 62k | 2.70 | |
| Kodiak Sciences (KOD) | 0.1 | $135k | 20k | 6.90 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $126k | 18k | 7.04 | |
| Abcellera Biologics (ABCL) | 0.1 | $81k | 13k | 6.46 | |
| Cerus Corporation (CERS) | 0.0 | $35k | 14k | 2.46 | |
| Athira Pharma (ATHA) | 0.0 | $35k | 12k | 2.95 |
